FDA Finalizing Review Principles Guidance; Complete Submissions Urged
Executive Summary
FDA's guidance on good review management principles is entering the final clearance stage, Office of New Drugs Director John Jenkins, MD, said during the Drug Information Association annual meeting in Washington, D.C. June 16
You may also be interested in...
Good Review Management Guidance To Be Tested By “Root Causes” Analysis
FDA will evaluate the impact of its Good Review Management Principles project through a prospective analysis of NME submissions, beginning with fiscal year 2005
Good Review Management Guidance To Be Tested By “Root Causes” Analysis
FDA will evaluate the impact of its Good Review Management Principles project through a prospective analysis of NME submissions, beginning with fiscal year 2005
Second Continuous Marketing Application Pilot Program Is 44% Enrolled
Enrollment in FDA's second continuous marketing application pilot program is nearly 50% enrolled